School of Medicine


Showing 12,781-12,790 of 12,942 Results

  • Lu Zhang

    Lu Zhang

    Postdoctoral Scholar, Endocrinology and Metabolism

    BioLu is a postdoctoral research scholar in Dr. Anna Gloyn's Translational Genomics of Diabetes Lab. During her master's and doctoral studies, she focused on epigenomics and single-cell multi-omics analysis, with an emphasis on 3D genomics. Her research included developing Hi-Tag, a chromatin conformation capture technique designed for use with small cell samples. This method provides valuable insights into the organization of chromatin in the cell. She has built strong expertise in combining different types of biological data, including RNA-seq, ATAC-seq, chromatin interaction data, and single-cell data. She has contributed to several research projects as a co-author, including studies that used genome-wide association studies (GWAS) and GTEX data to connect multi-omics data with functional genomics. These experiences have helped her gain a deep understanding of how to integrate different types of genomic data to solve complex biological problems. Currently, Lu is focused on applying her research skills to diabetes.

  • Mengrui Zhang

    Mengrui Zhang

    Senior Biostatistician, Med/Quantitative Sciences Unit

    BioMengrui’s research focuses on leveraging advanced statistical and machine-learning techniques to extract meaningful insights from complex biological datasets. His research interests include bioinformatics, deep learning/machine learning, statistical testing, high-dimensional data, non-parametric modeling, time series analysis, and spatial statistics. Additionally, he is also interested in developing new methods, tools, and pipelines for various kinds of biological datasets, especially in single cell, RNA-Seq, metagenomics, and proteomics to support drug discovery and development.

  • Niushen Zhang

    Niushen Zhang

    Clinical Associate Professor, Adult Neurology

    BioDr. Niushen Zhang is a board-certified neurologist and Chief of the Headache and Facial Pain Division in the Department of Neurology. She has a special interest in developing personalized treatment plans for headache patients which incorporate the use of complementary and integrative medicine. She is the Chair of the Complementary and Integrative Medicine Special Interest Section of the American Headache Society (AHS). Her research interests include the connection between the gut microbiome and migraine and the impact of diet and nutrition on migraine. In addition, she participates in clinical trials of new headache treatments for migraine and cluster headache. Dr. Zhang is also actively involved in medical education. She is the Director of the Headache Fellowship Program at Stanford. She serves as the Co-Chair of the Headache Fellowship Directors Committee for the American Headache Society (AHS). She is also a curriculum developer for AHS's REACH Program. She spearheaded the design and creation of the AHS National Headache Fellowship Opportunities website which serves as a central resource for all headache fellowship applicants and promotes the AAN's unified fellowship application timeline.

    Dr. Zhang graduated from Yale University with a Bachelor of Science degree in Molecular, Cellular and Developmental Biology. She earned an MD from the New York University School of Medicine. She completed neurology residency and fellowship in headache and facial pain at Stanford University.

  • Peng Zhang

    Peng Zhang

    Affiliate, Cardiovascular Institute Operations
    Visiting Postdoctoral Scholar, Cardiovascular Institute Operations

    BioPhD in Integrative Medicine with research focus on elucidating the molecular and cellular mechanisms underlying immune-metabolic disorders, including but not limited to cardiovascular diseases, bone diseases, and autoimmune diseases. My work integrates traditional Chinese medicine (TCM) theories with modern biomedical approaches, employing techniques such as multi-omics analysis, network pharmacology, and in vivo/in vitro disease modeling to explore novel therapeutic strategies and biomarker discovery.